Aj Pharma Consulting Ltd
Research and experimental development on biotechnology
Aj Pharma Consulting Ltd contacts: address, phone, fax, email, website, shedule
Address: 5 Demelza Close Cuxton ME2 1ED Rochester
Phone: +44-1487 2452941
Fax: +44-1487 2452941
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Aj Pharma Consulting Ltd"? - send email to us!
Registration data Aj Pharma Consulting Ltd
Register date: 2013-06-20
Register number: 08577424
Type of company: Private Limited Company
Get full report form global database UK for Aj Pharma Consulting LtdOwner, director, manager of Aj Pharma Consulting Ltd
Alison Jones Director. Address: Demelza Close, Cuxton, Rochester, Kent, ME2 1ED, United Kingdom. DoB: January 1974, British
Jobs in Aj Pharma Consulting Ltd vacancies. Career and practice on Aj Pharma Consulting Ltd. Working and traineeship
Fabricator. From GBP 2800
Controller. From GBP 2600
Other personal. From GBP 1200
Responds for Aj Pharma Consulting Ltd on FaceBook
Read more comments for Aj Pharma Consulting Ltd. Leave a respond Aj Pharma Consulting Ltd in social networks. Aj Pharma Consulting Ltd on Facebook and Google+, LinkedIn, MySpaceAddress Aj Pharma Consulting Ltd on google map
Other similar UK companies as Aj Pharma Consulting Ltd: Berkley Finance Limited | Lomet Limited | Oestfold Kranbilservice Ltd | Toftstone Limited | Triumph Ltd
08577424 is a registration number used by Aj Pharma Consulting Ltd. This company was registered as a PLC on Thursday 20th June 2013. This company has been operating on the British market for the last 3 years. This firm is found at 5 Demelza Close Cuxton in Rochester. The office postal code assigned to this location is ME2 1ED. This firm Standard Industrial Classification Code is 72110 which stands for Research and experimental development on biotechnology. The company's most recent financial reports were filed up to 30th September 2014 and the most current annual return information was filed on 20th June 2014.
Alison Jones is this specific enterprise's individual director, that was given the job in 2013.
